Evidence-based·Updated November 20, 2026·How we grade evidence

SLU-PP-332

OtherExercise mimetic (research compound)

SLU-PP-332 has been studied only in cells and mice, mostly by the group that developed it. In mice given injections twice a day, it lengthened treadmill running, limited fat gain on a high-fat diet, and protected the heart and the aging kidney in disease models. It has never been given to people in a published study, so there are no human benefits, safety data or doses. Its developers report it is not absorbed well by mouth. It is not FDA-approved.

Taking SLU-PP-332 with other supplements or medications?Check your whole list for interactions. Free, no account.

Research compound: not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.

Quick decision guide

May help most

No approved or proven use; laboratory research only

Common dosing range

No approved or established dose for people. Mouse studies injected 50 mg per kg into the abdomen twice daily

When to expect effects

Not established in people

Watch out for

Not FDA-approved and never tested in people, so its safety is unknown; its developers report it lacks oral bioavailability; products sold online have no FDA review of identity, purity or dose; anti-doping laboratories have developed tests for it

What is it

SLU-PP-332 is a lab-made research compound, not an approved drug or a dietary supplement: it is not FDA-approved for any use, and on November 19, 2026 we found no published study in people on PubMed and no registered trial on ClinicalTrials.gov. Chemically it is (E)-4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide, a small molecule made by researchers at Saint Louis University and colleagues to switch on the estrogen-related receptors (ERR alpha, beta and gamma). Despite the name, these are not estrogen receptors: they are "orphan" receptors inside cells that control genes for energy production in mitochondria. Because it set off exercise-like gene changes and longer running in mice, it is called an "exercise mimetic". Its developers later reported that SLU-PP-332 lacks oral bioavailability and made a different compound, SLU-PP-915, that works by mouth in mice. Several of the developers declare stock in companies developing ERR-based medicines (Myonid Therapeutics and Pelagos Pharmaceuticals). Anti-doping laboratories in the US and Germany published methods in 2026 to detect it and its breakdown products.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

A registered clinical trial of SLU-PP-332 or a related ERR agonist opens and you qualify, under medical supervision (none was listed on ClinicalTrials.gov on November 19, 2026)
You want the benefits it is promoted for (endurance, fat loss, heart or metabolic health): talk to a doctor about exercise programs and approved treatments that have been tested in people

Probably skip if…

You would be buying capsules, powders or injections online, including "research use only" products: their identity, purity and dose are unverified, and the compound has never been tested in people
You expect the mouse results to apply to you: no human study exists
You are pregnant, breastfeeding or planning a pregnancy: there are no data
You take prescription medicines: no interaction studies exist, and how people break it down is known only from lab tests
You compete in sport under anti-doping rules: anti-doping laboratories have published methods to detect it

Evidence at a glance

exercise endurance and body fat in mice

Mixed Evidence
Effect
About 70% longer running time and 12% lower body weight than untreated mice
Best fit
None in people
Time
Days to 4 weeks in mice

heart failure and kidney aging in mice

Mixed Evidence
Effect
Better heart pumping and survival in mice with heart failure; less albuminuria in old mice
Best fit
None in people
Time
Weeks in mice

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

exercise endurance and body fat in mice

Mechanism only
Mixed Evidence

In mice, SLU-PP-332 injected into the abdomen (50 mg per kg twice daily) increased oxidative muscle fibers, and in a treadmill test treated mice ran about 70% longer and about 45% farther than untreated mice; grip strength rose after 2 weeks. In obese mice kept on a high-fat diet, 28 days of the same injections left them about 12% lighter than untreated mice, and they gained less than 0.5 g of fat compared with about 5 g in untreated mice, with no change in food intake or lean mass. In muscle cells taken from 10 inactive women during hip surgery and grown in a dish, SLU-PP-332 raised markers of mitochondrial activity and reduced markers of oxidative stress and cell aging. These are animal and cell results and have never been tested in people. The developers declare stock in companies developing ERR-based medicines.

Effect size
About 70% longer running time and 12% lower body weight than untreated mice
Time to effect
Days to 4 weeks in mice
Best fit
None in people
Less likely
People seeking fat loss or better fitness, who have not been studied

Bottom line: SLU-PP-332 made injected mice run longer and gain less fat, but it has never been tested in people.

heart failure and kidney aging in mice

Mechanism only
Mixed Evidence

In mice with heart failure caused by surgically narrowing the aorta (pressure overload), SLU-PP-332 and a related compound, SLU-PP-915, improved the heart's pumping (ejection fraction), reduced scarring (fibrosis) and increased survival, without changing heart muscle thickening; the effect worked mainly through ERR gamma. In 21-month-old mice, 8 weeks of SLU-PP-332 reversed age-related increases in protein in the urine (albuminuria), loss of kidney filter cells (podocytes), mitochondrial dysfunction and inflammatory signals. These are mouse results and have not been tested in people with heart or kidney disease.

Effect size
Better heart pumping and survival in mice with heart failure; less albuminuria in old mice
Time to effect
Weeks in mice
Best fit
None in people
Less likely
People with heart failure or kidney disease, who need proven treatment

Bottom line: Mouse heart and kidney results are early laboratory findings, not evidence of benefit in people.

How it works

In cell tests, SLU-PP-332 activated all three ERRs, most strongly ERR alpha (half-maximal activity at 98 nM, compared with 230 nM for ERR beta and 430 nM for ERR gamma). In a skeletal muscle cell line it raised mitochondrial activity and cell respiration. In mice it increased the share of oxidative (type IIa) muscle fibers and switched on genes that normally rise after a bout of aerobic exercise, such as Ddit4; the endurance effect depended on ERR alpha. In heart studies in mice, the protective effect ran mainly through ERR gamma. Two hours after one 30 mg per kg injection into the abdomen of mice, levels were about 0.6 micromolar in muscle and 0.2 micromolar in blood. Every effect reported so far comes from injections into the abdomen of mice or from cells in a dish. The developers state that SLU-PP-332 lacks oral bioavailability, so it is not known whether a capsule swallowed by a person delivers any active compound. In lab tests with human liver preparations, it was broken down into many products (9 in one study, 22 in another); what these do in the body is unknown.

How to take it

1. Typical dose
There is no approved or established dose for people, and no dose has ever been tested in people. In mouse studies, researchers injected 50 mg per kg of body weight into the abdomen twice a day for 7 to 28 days, and used a single 30 mg per kg injection to measure blood and muscle levels. These are animal research doses, not recommendations, and they do not translate into a human dose.
2. Higher studied dose
No human dose has been studied.
3. Timing
Not established.
4. With food
Not established. Its developers report that SLU-PP-332 lacks oral bioavailability.
5. Split dosing
Not established.
6. How long to try
Mouse studies lasted from one dose to 8 weeks. There are no human data of any duration.

What to track

If you have used it: tell your doctor and pharmacist, and bring the product
Any new or unusual symptom, such as chest pain, a racing heartbeat or shortness of breath: get medical care
Athletes: anti-doping laboratories have published methods to detect it

Bottom line: No human dose exists, and nothing sold under this name has been tested in people.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Unknown: SLU-PP-332 has never been given to people in a published study, so no side-effect profile existsIn mice injected twice daily for 10 days, the developers reported no overt toxicity, with normal blood counts, electrolytes and creatine kinase; in their later obesity study, the experiment in genetically obese (ob/ob) mice was shortened to 12 days because these mice tolerated the twice-daily abdominal injections less well (animal findings, not a human safety result)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

There are no human data on SLU-PP-332 in pregnancy, breastfeeding or fertility, and the 2026 systematic review found only animal and cell studies of other outcomes. Avoid use if you are pregnant, breastfeeding or planning a pregnancy, and talk to your doctor.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

There is no FDA-approved SLU-PP-332 product, so no label can show FDA approval
Labels saying "for research use only" or "not for human consumption" mean the product was not made or tested for people
The legitimate way to receive an experimental compound like this is a registered clinical trial listed on ClinicalTrials.gov; none was listed for SLU-PP-332 on November 19, 2026

Be skeptical of…

"Exercise in a pill" or "replaces your workout": shown only in mice given injections
"Clinically proven fat loss" or "burns fat while you rest": no human study exists
"Heart health" or "kidney anti-aging": mouse disease models only
"Safe" or "no side effects": it has never been tested in people
Oral capsules that "work like the studies": the developers report it lacks oral bioavailability, and the mouse effects came from injections
"Undetectable" or "safe for drug-tested athletes": anti-doping laboratories have published methods to detect it
"Estrogen booster" or hormone claims: estrogen-related receptors are not estrogen receptors

Frequently asked questions

Is SLU-PP-332 FDA-approved?⌄

No. SLU-PP-332 is an experimental lab compound. It is not approved by FDA for any use, and it has not completed any of the safety testing an approved medicine goes through.

Has SLU-PP-332 been tested in people?⌄

No. On November 19, 2026 we found no published human study on PubMed and no registered trial on ClinicalTrials.gov. The closest work used muscle cells from 10 women grown in a dish. A 2026 systematic review found only animal and cell studies and said clinical trials are needed.

Is it really "exercise in a pill"?⌄

Only in mice. Mice given injections of SLU-PP-332 ran about 70% longer on a treadmill, and obese mice gained less fat. Mouse results often do not carry over to people, and no one knows what dose, if any, would do this in a person, or what the risks would be. Exercise itself has proven benefits.

Do SLU-PP-332 capsules work by mouth?⌄

That is unknown. Its developers report that SLU-PP-332 lacks oral bioavailability, and all of the mouse results came from injections into the abdomen. They made a different compound, SLU-PP-915, that works by mouth in mice; it has not been tested in people either.

Is SLU-PP-332 banned in sport?⌄

WADA's online Prohibited List search returned no entry named SLU-PP-332 on November 19, 2026. WADA states that its section S0 covers substances not approved by any health authority for human use, including drugs in pre-clinical development, and that a substance missing from the list is not necessarily permitted. The UCLA anti-doping laboratory notes that WADA prohibits exercise mimetics and metabolic modulators, and laboratories have published tests for it. Athletes should check with their anti-doping organization.

Can I take SLU-PP-332 with my supplements or medicines?⌄

No interaction studies exist, and it has never been studied in people. Ask a doctor or pharmacist to review your full list, and tell them if you have used it.

References by claim

exercise endurance and body fat in mice

Billon et al., 2023 · PMC (2023) link

Billon et al., 2024 · PMC (2024) link

Bonanni et al., 2025 · PMC (2025) link

heart failure and kidney aging in mice

Xu et al., 2024 · PMC (2024) link

Wang et al., 2023 · PMC (2023) link

Safety

de Souza-Lima et al., 2026 · PubMed (2026) link

ClinicalTrials.gov search for SLU-PP-332 (no registered studies, checked November 19, 2026) · ClinicalTrials.gov link

Avliyakulov et al., 2026 · PubMed (2026) link

Möller et al., 2026 · PMC (2026) link

Billon et al., 2026 · PubMed (2026) link

Track SLU-PP-332 with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.